Literature DB >> 27255221

Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.

J Serra-Pladevall1,2, M J Barberá3, S Rodriguez4, R Bartolomé-Comas5,6, G Roig5, R Juvé5, A Andreu5,6.   

Abstract

The aims of this study were to determine the antimicrobial susceptibility of Neisseria gonorrhoeae (NG) in our area, to analyze the molecular mechanisms involved in cephalosporins resistance, and to undertake molecular typing of our NG strains. Antimicrobial susceptibility was determined using the Etest. The genes penA, mtrR, penB, and ponA were studied. Molecular typing was performed by N. gonorrhoeae multiantigen sequence typing. Of 329 strains analyzed in 2013, none showed high-level cephalosporin resistance, but 8.2 % had resistance to cefixime [minimum inhibitory concentration (MIC) > 0.125 μg/mL] and 0.6 % to ceftriaxone (MIC > 0.125 μg/mL). Azithromycin resistance was documented in 4.3 % and ciprofloxacin resistance in 49.2 %. Among 48 strains with an MIC ≥ 0.125 μg/mL to cefixime, 58.3 % showed the penA mosaic pattern XXXIV, 98 % a Leu → Pro substitution at position 421 of the ponA gene, 100 % amino acid changes at positions 101 and 102 of the PorB1b porin, and 87.5 % of strains an adenine deletion in the promoter region of the MtrC-D-E efflux pump. A significant difference between strains with and without decreased cephalosporin susceptibility (MIC ≥ 0.125 μg/mL) was observed for these four genes. Of the 48 strains with an MIC ≥ 0.125 μg/mL to cefixime, 43.8 % belonged to the genogroup G1407 and 27.1 % belonged to the genogroup G2400. A significant association of G1407 with decreased susceptibility (MIC ≥ 0.125 μg/mL) and G2992 with susceptibility was found, and also between G1407 and mosaic pattern XXXIV and between G2400 and A501T substitution in penA. The NG resistance rate in our area is higher than the median of Europe. We have detected the emergence of G2400, which may be a source of antimicrobial resistance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27255221     DOI: 10.1007/s10096-016-2696-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  The emerging threat of untreatable gonococcal infection.

Authors:  Gail A Bolan; P Frederick Sparling; Judith N Wasserheit
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

2.  Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Authors:  C A Ison; J Hussey; K N Sankar; J Evans; S Alexander
Journal:  Euro Surveill       Date:  2011-04-07

3.  Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.

Authors:  Irene Martin; Pam Sawatzky; Vanessa Allen; Linda Hoang; Brigitte Lefebvre; Neil Mina; Tom Wong; Matthew Gilmour
Journal:  Sex Transm Dis       Date:  2012-04       Impact factor: 2.830

4.  Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone.

Authors:  S A Chisholm; M Unemo; N Quaye; E Johansson; M J Cole; C A Ison; M J Van de Laar
Journal:  Euro Surveill       Date:  2013-01-17

5.  Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.

Authors:  Raymond Heymans; Sylvia M Bruisten; Daniel Golparian; Magnus Unemo; Henry J C de Vries; Alje P van Dam
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

Review 6.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

7.  [Neisseria gonorrhoeae: antimicrobial resistance and study of population dynamics. Situation in Barcelona in 2011].

Authors:  Judit Serra-Pladevall; María Jesús Barberá-Gracia; Glòria Roig-Carbajosa; Rosa Juvé-Saumell; Juan José Gonzalez-Lopez; Rosa Bartolomé-Comas; Antònia Andreu-Domingo
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-04-25       Impact factor: 1.731

8.  High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Authors:  Magnus Unemo; Daniel Golparian; Robert Nicholas; Makoto Ohnishi; Anne Gallay; Patrice Sednaoui
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

9.  Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.

Authors:  Jordi Cámara; Judit Serra; Josefina Ayats; Teresa Bastida; Dolors Carnicer-Pont; Antònia Andreu; Carmen Ardanuy
Journal:  J Antimicrob Chemother       Date:  2012-05-07       Impact factor: 5.790

10.  Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012.

Authors:  Anna Carannante; Giovanna Renna; Ivano Dal Conte; Valeria Ghisetti; Alberto Matteelli; Grazia Prignano; Giampaolo Impara; Marco Cusini; Antonietta D'Antuono; Caterina Vocale; Raffaele Antonetti; Marina Gaino; Marina Busetti; Maria Agnese Latino; Antonella Mencacci; Carmen Bonanno; Maria Carmela Cava; Cristina Giraldi; Paola Stefanelli
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

View more
  7 in total

1.  Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness.

Authors:  Joshua Tomberg; Alena Fedarovich; Leah R Vincent; Ann E Jerse; Magnus Unemo; Christopher Davies; Robert A Nicholas
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

2.  penA, ponA, porB1, and mtrR Mutations and Molecular Epidemiological Typing of Neisseria gonorrhoeae with Decreased Susceptibility to Cephalosporins.

Authors:  Kayo Osawa; Katsumi Shigemura; Yukie Nukata; Koichi Kitagawa; Fukashi Yamamichi; Hiroyuki Yoshida; Toshiro Shirakawa; Soichi Arakawa; Masato Fujisawa
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 3.  Drug-resistant Neisseria gonorrhoeae: latest developments.

Authors:  B Suay-García; M T Pérez-Gracia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-16       Impact factor: 3.267

4.  Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.

Authors:  Xiaomeng Deng; Jeffrey D Klausner
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

5.  Using the genetic characteristics of Neisseria gonorrhoeae strains with decreased susceptibility to cefixime to develop a molecular assay to predict cefixime susceptibility.

Authors:  Xiaomeng Deng; Lao-Tzu Allan-Blitz; Jeffrey D Klausner
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

6.  Differences in Neisseria gonorrhoeae population structure and antimicrobial resistance pattern between men who have sex with men and heterosexuals.

Authors:  J Serra-Pladevall; M J Barberá; A E Callarisa; R Bartolomé-Comas; A Andreu
Journal:  Epidemiol Infect       Date:  2016-10-19       Impact factor: 4.434

7.  Epidemiology, molecular characterisation and antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Madrid, Spain, in 2016.

Authors:  M D Guerrero-Torres; M B Menéndez; C S Guerras; E Tello; J Ballesteros; P Clavo; T Puerta; M Vera; O Ayerdi; J C Carrio; I Mozo; J Del Romero; J A Vázquez; R Abad
Journal:  Epidemiol Infect       Date:  2019-09-24       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.